MENU
FEB 24, 2021 10:30 AM PST

The Visiopharm Platform: Flexible tools to solve real-world problems

Sponsored by: Visiopharm®
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Senior Business Development Manager, OracleBio
    Biography

      Keith has worked in the Pharmaceutical industry for over 25 years, with experience in large Pharma, Biotech and the contract services sector. He has held positions of both scientific, project and people leadership, with experience across the drug development pipeline, from HTS to through to early clinical development support, including biomarker and translational science studies.

    • Technical Sales Specialist, Visiopharm
      Biography

        Dave Mason is a Technical Specialist in Image Analysis supporting Visiopharm’s UK and European Sales team. Trained as a Cell Biologist and Microbiologist he has spent over a decade in Academia specializing in Light Microscopy and Digital Image Analysis.


      Abstract

      Image analysis in a real-world situation rarely involves solving a single unchanging problem. Modern tools need to be flexible and adaptable not only to solve todays problems but to support tomorrows workflows. In this webinar, Technical Specialist David Mason will use examples to demonstrate the flexible tools available within the Visiopharm platform and how they can be used to support a wide range of Image Analysis workflows.

      To demonstrate how these tools can be scaled up and used in a real-life situation, Senior Business Development Manager Keith Bowers will discuss how Visiopharm’s flexible platform is used at OracleBio, a leader in advanced quantitative image analysis for Pharma R&D. Keith will highlight how these tools are integrated into a customer centric, scalable workflow to generate value for drug discovery & development projects.

      Learning Objectives:

      1. Address dynamic nature of image analysis and the need for adaptable and flexible solutions to support evolving workflows

      2. Provide an overview of how Visiopharms capabilities and how they can be used to support image analysis workflows

      3. Demonstrate how OracleBio integrates Visiophrm software into their workflow to generate value for drug discovery and development projects


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      APR 01, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      MAR 16, 2021 10:00 AM PDT
      C.E. CREDITS
      MAR 16, 2021 10:00 AM PDT
      Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
      Loading Comments...
      Show Resources
      Attendees
      • See more